Drug Profile
Rocuronium bromide
Alternative Names: Eslax; Esmeron; ORG 9426; ZemuronLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Organon
- Developer Schering-Plough
- Class Androstanols; Muscle relaxants
- Mechanism of Action Cholinergic receptor modulators; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Muscle hypertonia
Most Recent Events
- 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
- 19 Nov 2007 Organon has been acquired by Schering-Plough
- 02 Oct 2007 Launched for Hypertonia in Japan (IV)